TMEM132C Activators

Chemical activators of TMEM132C can initiate a cascade of intracellular events that lead to the functional activation of this protein. Phorbol 12-myristate 13-acetate (PMA) directly activates protein kinase C (PKC), which then phosphorylates TMEM132C, leading to its activation. Forskolin works by increasing intracellular cAMP, subsequently activating protein kinase A (PKA), which also targets TMEM132C for phosphorylation and activation. Ionomycin raises intracellular calcium levels, triggering the activation of calcium-dependent protein kinases that can phosphorylate and activate TMEM132C. Thapsigargin, by inhibiting the SERCA pump, similarly increases intracellular calcium, which has a knock-on effect of activating kinases that can phosphorylate TMEM132C. Okadaic acid prevents the dephosphorylation of TMEM132C by inhibiting protein phosphatases PP1 and PP2A, resulting in a net increase in TMEM132C phosphorylation and activation. Calyculin A operates in a comparable manner to Okadaic acid, maintaining TMEM132C in a phosphorylated state.

Additionally, Anisomycin activates stress-activated protein kinases, which can target TMEM132C for phosphorylation. Epigallocatechin gallate (EGCG) inhibits phosphodiesterases, leading to elevated cAMP levels and subsequent activation of PKA, which then activates TMEM132C. Sphingosine, once converted to sphingosine-1-phosphate, can activate kinases that phosphorylate TMEM132C. Dibutyryl-cAMP (db-cAMP) and 8-Bromo-cAMP act as cAMP analogs to directly activate PKA, which in turn phosphorylates and activates TMEM132C. Bryostatin 1 modulates PKC to an active state; PKC can then phosphorylate TMEM132C, culminating in its activation. Collectively, these chemicals target various kinases or modulate intracellular signaling molecules that lead to the phosphorylation and activation of TMEM132C, demonstrating multiple cellular pathways through which this protein can be functionally activated.